[1]中国防痨协会. 耐药结核病化学治疗指南(2009). 中国防痨杂志,2010,32(4):181-198.[2]Prasad R, Verma SK, Sahai S, et al. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients. Indian J Chest Dis Allied Sci,2006,48(3):183-186.[3]Tahaoglu K, Torün T, Sevim T, et al. The treatment of multidrug-resistant tuberculosis in Turkey. N Engl J Med,2001,345(3):170-174.[4]Masjedi MR, Tabarsi P, Chitsaz E, et al. Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002—2006. Int J Tuberc Lung Dis,2008,12(7):750-755.[5]缪昌东,姜继军. 环丝氨酸致精神异常一例. 中国防痨杂志,2013,35(6):480.[6]谢安,肖和平. 环丝氨酸在治疗耐多药结核病方面的应用. 中华结核和呼吸杂志,2012,35(12):949-950. |